Nicotine, in the form of tobacco, is the most commonly used drug of abuse. In addition to its rewarding properties, nicotine also affects many cognitive and emotional processes that involve several brain regions, including hippocampus and amygdala. Long-term changes in synaptic strength in these brain regions after drug exposure may be importantly correlated with behavioral changes induced by nicotine. Here, we study the effect of chronic oral administration of nicotine on the long-term synaptic potentiation in the amygdala, a key structure for emotional memory. We find that oral administration of nicotine for 7 d produces a significant enhancement of LTP in the amygdala. This facilitation is pathway specific: Nicotine selectively facilitates LTP in the cortical-lateral amygdala pathway, but not the thalamic-lateral and the lateral-basolateral synaptic pathway. The synaptic facilitation induced by a 7-d exposure to nicotine is long-lasting, it persists for 72 h after cessation of nicotine but decays 8 d after its cessation. In contrast, a shorter exposure of nicotine (24 h) induces only a short-lasting facilitation of synaptic plasticity that dissipates 24 and 72 h after cessation of nicotine. The facilitation of LTP in the amygdala after exposure to nicotine is mediated by removal of GABAergic inhibition, is dependent on the activation NMDA receptors, and can be prevented by blocking either ␣7 or ␤2 nACh receptors. Our results indicate that chronic exposure to nicotine can promote the induction of long-lasting modifications of synapses in a specific pathway in the amygdala.These changes in synaptic plasticity may contribute to the complex neural adaptations and behaviors caused by nicotine.
Nicotine derived from tobacco is one of the most commonly used drugs of abuse. However, the cellular mechanisms underlying the effects of nicotine are not well understood. Previous studies on the neural mechanism underlying nicotine addiction have mainly focused on the effects of nicotine in the brain reward system such as the ventral tegemental area (VTA) and nucleus accumbens (Nac) McGehee 2000, 2002; Dani et al. 2001) . In contrast, the effects of nicotine on learning-related emotional systems are less well known.
Nicotine is known to enhance many cognitive processes. For instance, nicotine enhances spatial working memory in the radial-arm maze and the Morris water maze in rodents (Levin 1992; Socci et al.1995) . Nicotine also facilitates fear conditioning, such as contextual fear conditioning and trace fear conditioning (Gould and Higgins 2003; Gould et al. 2004; Davis et al. 2006 ). In addition, nicotine dependence (tobacco use) is related to the development of certain forms of anxiety disorders (Sonntag et al. 2000; Morissette et al. 2007 ). All of these nicotine-induced behavioral changes involve both the hippocampus and the amygdala. Several previous studies have shown that nicotine facilitates the induction of long-term potentaition (LTP) in the hippocampus. Bath application or systemic administration of nicotine enhances LTP in the CA1 region and in the dentate gyrus in the hippocampus (Fujii et al. 1999 (Fujii et al. , 2000 Welsby et al. 2007 ). Nicotine converts short-term potentiation (STP) into LTP in the hippocampal CA1 region (Welsby et al. 2006 ) and reverts the impairment in LTP induction induced by a cholinergic lesion (Yamazaki et al. 2002) . In contrast, the effect of chronic, in vivo exposure to nicotine on synaptic plasticity in the amygdala is not known.
The basolateral amygdala (BA) complex, which contains the lateral, basolateral, and basomedial nuclei, is thought to be the site for the formation and storage of fear memory. The synaptic facilitation produced by fear conditioning and the LTP elicited by electrical stimulation in the amygdala are thought to share a common synaptic mechanism (Rogan et al. 1997; Huang and Kandel 1998; Tsvetkov et al. 2002; Schroeder and ShinickGallagher 2005) . It is therefore of interest to explore the changes induced by nicotine on synaptic plasticity in that region.
The fear circuit in the amygdala contains different synaptic pathways, and these pathways may play different roles in fear memory. We asked first: Does nicotine administration affect synaptic plasticity in all pathways in amygdala, or does it selectively affect some synaptic pathways and not others? Second, since nicotine activates various subtypes of nicotine acetylcholine receptors (nAChRs), which functional receptor subtype mediates the effect of nicotine in the amygdala? Third, since the activation of NMDA receptors is critical for the induction of LTP in the amygdala and for amygdala-dependent fear memory (Bauer et al. 2002) , is the nicotine effect mediated by NMDA receptors? Finally, we wanted to determine the time course of the plastic changes induced by chronic nicotine exposure: How long do the nicotine-induced synaptic changes last after cessation of nicotine, and what is the difference between short-term and longterm exposure to nicotine on these plastic changes?
Results

Pathway specific facilitation of nicotine
In most studies of LTP in amygdala slices, GABAergic antagonist picrotoxin (PTX) or bicuculline are administered in the bath to block the tonic inhibition of GABAergic interneuron (Huang and Kandel 1998; Rammes et al. 2000; Tsvetkov et al. 2002) . To examine the nicotine effect on synaptic plasticity in general, we checked LTP with intact GABAergic inhibition (without PTX), followed later by measurement of LTP in the presence of GABAergic antagonist in the bath.
In the cortical-lateral amygdala (LA) pathway, which transmits sensory information during fear conditioning, with inhibition intact, repeated highfrequency stimulation (HFS, 6 ‫ן‬ 100 H z ) o n l y i n d u c e s a m o d e s t L T P (117 ‫ע‬ 6%, n = 8, measured 60 min after the first tetanus) in controls (mice drinking tap water). However, in slices from mice treated with nicotine (10 µg/mL) for 7 d, the same tetanic stimulation induces a much greater amplitude of LTP (140 ‫ע‬ 5%, n = 10, measured 60 min after tetanization) (Fig. 1A2) , which is significantly larger than LTP in control slices (P < 0.01). The facilitation of LTP induced by nicotine is activity dependent, and there is no facilitation of LTP by a single tetanic stimulation (1 ‫ן‬ 100 Hz; control: 110 ‫ע‬ 6%, n = 6; nicotine: 104 ‫ע‬ 4%, n = 6; P > 0.05) (Fig. 1B) . Nicotine-induced enhancement of LTP is also dose dependent. Exposure of a lower dose of nicotine (2 µg/mL) did not produce any significant increase of LTP (122 ‫ע‬ 5%, n = 5; P > 0.05), and a higher dose of nicotine (25 µg/mL) produced a smaller increase of LTP than 10 µg/mL treatment (133 ‫ע‬ 3%, n = 7) but is still significantly greater than LTP in control mice (P < 0.05). Thus, nicotineinduced facilitation of LTP in the amygdala shows an inverted U-shape dose response curve. Dose-dependent changes of LTP induced by 7-d nicotine exposure are shown in Figure 1C . The facilitation of LTP is not associated with the changes in the input-output curve in this pathway (Fig. 1D) . Interestingly, nicotineinduced facilitation of LTP is pathway specific. In the pathway from thalamus (TH) to the LA (TH-LA), which conveys sensory information directly to the LA, the same tetanic stimulation did not induce significant LTP (108 ‫ע‬ 11%, n = 6; P > 0.05) (Shin et al. 2006) , and nicotine exposure did not produce any significant facilitation of LTP (112 ‫ע‬ 10%, n = 7; P > 0.05) (Fig. 2A2) . Similarly, nicotine treatment did not induce any significant facilitation of LTP in projective pathway from lateral (LA) to basolateral (BL) amygdala (nicotine: 122 ‫ע‬ 9%, n = 7; control: 109 ‫ע‬ 3%, n = 6; P > 0.05) (Fig.  2B2) . A comparison of plastic changes in the three different pathways is shown in Figure 2C . These results indicate that nicotineinduced facilitation of LTP in the amygdala circuitry is pathway specific and that the pathway from cortex to the LA is highly sensitive to nicotine-induced changes of synaptic plasticity.
Time course of nicotine-induced synaptic facilitation
Persistence is an important feature of long-term synaptic potentiation. Different forms of LTP may have different underlying cellular and molecular mechanisms. In the hippocampus, facilitation induced by chronic nicotine exposure required 10 d of intraperitoneal (i.p) injections, and the facilitated LTP was significantly reduced 2 d after the cessation of nicotine (Yamazaki et al. 2006b ). We were interested in determining how long the facilitation of LTP in the amygdala lasts after oral administration of nicotine. We first examined long-term exposure to nicotine. In these experiments, we administered nicotine for 7 d perorally (p.o.) and measured LTP 24 h, 72 h, and 8 d after cessation of nicotine. We find that facilitation of LTP persisted 24 h after nicotine is stopped (nicotine: 139 ‫ע‬ 8%, n = 8; control: There is no significant difference of inputoutput curves between nicotine treated (closed squares) and control mice (close circles). *P < 0.05, **P < 0.01.
116 ‫ע‬ 5%, n = 7; P < 0.05) (Fig. 3A) . Even 3 d (72 h) after cessation of nicotine, LTP is still significantly greater than in control slices (nicotine: 140 ‫ע‬ 8%; control: 116 ‫ע‬ 5%; P < 0.05) (Fig.  3B) . However, by 8 d after cessation of nicotine, the facilitation completely disappears, and LTP in these mice is not significantly different from that of controls (nicotine: 114 ‫ע‬ 6%, n = 7; control: 117 ‫ע‬ 8%, n = 7; P > 0.05) (Fig. 3C ). The changes in LTP after various days of nicotine cessation are shown in Figure 3D .
We next examined LTP in slices from a short exposure (24 h) to nicotine. Surprisingly, we find that the formation of LTP facilitation in the amygdala is rapid. In mice exposed to nicotine for only 1 d (24 h), LTP in the amygdala i s g r e a t l y e n h a n c e d ( n i c o t i n e : 141 ‫ע‬ 6%, n = 7; control: 116 ‫ע‬ 5%, n = 7; P < 0.05) (Fig. 4A) , and the increase in LTP in mice exposed to nicotine for 24 h is not significantly different from that of 7-d exposure to nicotine (P > 0.05). However, we find that the persistence of LTP facilitation in mice treated with nicotine for 1 d and 7 d is different. In mice exposed to nicotine for 1 d, LTP decays quickly and returns to control as early as 24 h after cessation of nicotine (nicotine: 117 ‫ע‬ 8%, n = 8; control: 114 ‫ע‬ 6%, n = 7; P > 0.05) (Fig.  4B) , and there is no facilitation of LTP at 72 h (nicotine: 114 ‫ע‬ 7%, n = 7; control: 114 ‫ע‬ 6, n = 7; P > 0.05; Fig. 4C ). These results indicate that nicotine can produce different forms of LTP facilitation, depending on the exposure time. Longer exposure to nicotine produces more enduring facilitation of LTP in the amygdala, while short-term exposure to nicotine induces only a short-lasting facilitation of LTP, although the magnitude is surprisingly similar.
The facilitation of LTP requires activation of nicotine ␣7 and ␤2
ACh receptors
In our experiments, slices were incubated in a slice chamber for 2-3 h before recording. Because the half-life of nicotine is ∼55 min (Miller et al. 1977) , the effect we observed here is not a result of a direct action of residual nicotine in the brain. Chronic nicotine exposure may induce long-term alternations of nACh receptors and their signaling pathways. nAChRs are a multiple-gene family of ligand-gated ion channels that are involved in diverse brain functions. The density of ␤2-and ␣7-containing nAChRs is increased after chronic exposure to nicotine both in vivo and in vitro (Gaimarri et al. 2007 ). Ultrastructural studies have revealed the presence of both ␣7 and ␤2 subreceptors in amygdala neurons (Hill Jr. et al. 1993; Klein and Yakel 2006) . We asked the following: Is the activation of one or both of these receptor types required for nicotine-induced facilitation of LTP in the amygdala? We first examined the effect of a general nAChR antagonist macamylamine. When macamylamine (20 µM) is present in the bath, the facilitation of LTP induced by chronic nicotine exposure (10 µg/mL for 7 d) was significantly reduced (nicotine: 150 ‫ע‬ 4%, n = 7; nicotine + macamylamie: 126 ‫ע‬ 4%, n = 7; P < 0.05) (Fig. 5A) . To determine whether nicotine-induced facilitation of LTP in the amygdala involves ␣7 nACh receptors, we applied the ␣7 antagonist methyllycacanitine (MLA, 10 µM) to the bath 20 min prior to the HFS. In the presence of MLA, the facilitated effect of nicotine in slices is blocked (nicotine: 149 ‫ע‬ 4%; nicotine + MLA: 118 ‫ע‬ 4%; P < 0.05) (Fig. 5B ). Simi- Cold
larly, bath application of the ␤2 nAChR antagonist dihydeoµ-␤-erythroidine hydromide (D␤H, 20 µM) also completely blocks the facilitated effect in slices of mice that are treated with nicotine (nicotine: 147 ‫ע‬ 7%, n = 7; nicotine + D␤H, 118 ‫ע‬ 7%, n = 8; P < 0.05) (Fig. 5C ). The application of MLA (20 µM) and or D␤H (20 µM) does not alter the baseline amplitude of field potentials in nicotine slices (data not shown). These results indicate that the facilitation effect of nicotine on amygdala LTP is mediated by nAChRs and requires the activation of both ␣7 and ␤2 nAChR receptors.
Nicotine-induced facilitation of LTP is mediated by NMDA and GABA receptors
In hippocampal pyramidal neuron, nicotine enhances NMDA currents during tetanus and increases the NMDA/AMPA ratio (Yamazaki et al. 2006a,b) . We therefore asked the following: Is the facilitation of LTP in the amygdala mediated also by NMDA receptors? We perfused NMDA receptor antagonist D-APV (50 µM) into the bath and found that D-APV completely blocked the facilitation of LTP induced by chronic nicotine exposure (10 µg/ mL for 7 d). In the presence of D-APV, LTP is 110 ‫ע‬ 4% (n = 6). This is significantly different from LTP in nicotine slices in the absence of D-APV (147 ‫ע‬ 7%, n = 7, P < 0.01) (Fig. 6A ). In contrast to the NMDA-dependent LTP, which is induced by HFS, nicotine does not facilitate the slow-developed and NMDAindependent form of LTP induced by low-frequency stimulation (nicotine: 124 ‫ע‬ 5%, n = 5; control: 125 ‫ע‬ 6%, n = 5; measured 90 min after 1-Hz stimulation, P > 0.05) ( Fig. 6B ; Huang and Kandel 2007) . These results indicate that nicotine-induced facilitation of LTP in the amygdala is mediated by the activation of NMDA receptors.
In addition to glutamatergic input, amygdala neurons are under inhibitory control from GABAergic interneurons. Blockade of this inhibition causes a higher level of depolarization and larger NMDA currents during HFS. To determine whether the facilitation induced by nicotine is affected by blockade of GABAergic inhibition, we measured LTP in slices bathed with GABA-A antagonist PTX. In the presence of PTX (50 µM), no facilitation of LTP was observed in slices from mice with 7-d nicotine exposure (PTX control: 131 ‫ע‬ 7%, n = 6; nicotine + PTX: 126 ‫ע‬ 8%, n = 7; P > 0.05) (Fig. 6B ). This result indicates that the facilitation 
Discussion The concentrations of nicotine
In this study, we used a relatively low concentration of nicotine for oral administration. We preferred to use lower nicotine doses because we are primarily interested in the molecular events that happen at the beginning of the addiction process and did not want to confound our results with molecular changes that may signify the development of tolerance. It is important to note that the doses and levels of nicotine and cotinine in various rodent studies vary greatly, but also in human smokers, cotinine blood levels vary greatly. A smoker is defined as someone with cotinine blood level Ն10-15ng/mL, but the levels in smokers can range between 10-15 ng/mL and 650 ng/mL or even higher. The lower dose of nicotine was previously used in several other studies. For example, Zhu et al. (2005) and Agatsuma et al. (2006) used nicotine doses of 3.125 µg/mL, 6.25 µg/mL, and 12.5 µg/mL and showed behavioral differences even for the lower doses beginning at day 4 of treatment and certainly by day 7. Klein et al. (2004) used nicotine 10 µg/mL in the drinking water in an oral self-administration paradigm for 7 d and measured serum cotinine levels (a metabolite of nicotine that is more stable and therefore used to measure nicotine exposure). Cotinine levels in young male mice that were given nicotine 10 µg/mL were on average 20 ng/mL, which is within the range of the levels of cotinine in human smokers (in our samples we used older mice, which are expected to have even higher levels of cotinine because of a smaller liver/body ratio). Based on these studies, we chose to use 10 µg/mL and 25 µg/mL for our studies.
The pathway-specific facilitation of LTP
The LA is a key structure involved in the formation of memory for learned fear. During fear conditioning, auditory signals are sent to the LA directly via the thalamic-LA pathway (TH-LA) or indirectly via the cortical-LA pathway. One of the outputs of the LA is the projection to the BL (LA-BL) (Ledoux 2000) . These three synaptic pathways presumably play different roles in fear memory. Cortical-LA and TH-LA may be essential for the convergence of conditioned stimulation-unconditioned stimulation in the LA, while the LA-BL pathway may play a role in the expression, but not in the acquisition, of fear memory (Amorapanth et al. 2000) . In addition to having different function, the induction of LTP and LTD in these three pathways is also different. It includes a different induction threshold, a different time course, and a different amplitude of synaptic potentiation or depression. Among these pathways, the cortical-LA pathway is the most reactive (Shin et al. 2006; Huang and Kandel 2007; Sigurdsson et al. 2007 ). The differences in synaptic plasticity between these different pathways may be the result of different inhibitory influences caused by GABAergic interneurons (Heinbokel and Page 2000; Shin et al. 2006) , different structural features in the dendritic spine, and different AMPA receptor subunits (Humeau et al. 2005 (Humeau et al. , 2007 Sigurdsson et al. 2007 ). Behavioral studies show that the cortical-LA pathway is more critical for the storage of fear conditioning (Campeau and Davis 1995) . Conditioning stimulus may recruit the cortical-LA pathway, rather than the TH-LA pathway in fear memory retrieval ). Consistent with these findings, we here show that nicotine facilitates LTP only in the cortical pathway, and not in the TH-LA and LA-BL pathways. This pathway-specific feature of nicotine-induced synaptic facilitation may contribute to the selective influence of nicotine on certain forms of learning and memory and anxiety disorders (Sonntag et al. 2000; Gould et al. 2004; Davis et al. 2006; Morissette et al. 2007 ).
The role of NMDA receptors
Nicotine exposure facilitates the induction of LTP in the hippocampus. This effect is mediated by the action of nicotine on NMDA receptors. Nicotine enhances NMDA responses during a tetanic stimulation and increases the NMDA/AMPA ratio (Yamazaki et al. 2006a,b) . Here we find that nicotine-induced facilitation of LTP in the amygdala is blocked by D-APV, indicating that facilitation of LTP in the amygdala is also mediated by NMDA receptors. In the amygdala, activation of NMDA receptors is influenced by tonic inhibition from GABAergic interneurons, and GABAergic antagonists can favor the activation of NMDA receptors and facilitate the induction of LTP. In contrast, we observed in this study that nicotine-induced facilitation of LTP is blocked in slices treated with the GABA-A receptor antagonist PTX, indicating that nicotine-induced facilitation may also partially act through the attenuation of GABAergic tonic inhibition, which may be occluded in the PTX-treated slices. nACh receptors exist in GABAergic interneurons (Ji and Dani 2000; Kawai et al. 2002) , and the activation of nACh receptors can influence GABAergic synaptic transmission, leading to disinhibition of pyramidal neurons in several brain regions (Mansvelder and McGehee 2002; Yamazaki et al. 2005; Zhang and Berg 2007) . Therefore, it is likely that chronic exposure to nicotine activates nACh receptors located in interneurons and reduces GABAergic inhibition, which in turn facilitates the activation of NMDA receptor in pyramidal neurons, and enhances LTP. However, since the amplitude of LTP in the slices from nicotine-treated mice is much greater than that in the slices treated by PTX (cf. Figs. 1A2 and 6C) , the removal of GABAergic inhibition may not be the sole factor contributing to the nicotine-induced facilitation of LTP. Other nicotine-induced synaptic changes such as increased glutamate release from presynaptic terminal and increased Ca 2+ influx through the voltage-dependent calcium channel postsynaptically may also contribute to the facilitation effect (Mansvelder and McGehee 2000; Dani et al. 2001; Welsby et al. 2006 ).
The time course of nicotine-induced facilitation of LTP
Psychostimulants trigger multiple and complex neural adaptations that develop at different time courses ranging from hours to days. One important issue in the study of addiction is to determine a time course for the action of these drugs. When nicotine is administered p.o. to mice, they consume it in bouts, which mimics smoking behavior in humans. The up-regulation of nAChRs in the brain varies according to the time period of exposure to nicotine (Vezina et al. 2007) . Different time periods of nicotine exposure could therefore lead to a different time course of plastic changes in synapses. In most previous studies on the synaptic plasticity, nicotine was administered intraperitoneally (i.p.) and by subcutaneous injection, or by acute bath application into a slice chamber (Fujii et al. 1999; Matsuyama et al. 2000; Welsby et al. 2006; Yamazaki et al. 2006a; Nakauchi et al. 2007 ); the time course of the effect produced by chronic oral administration is unknown. We find in this study that chronic oral exposure to nicotine can produce different phases of synaptic facilitation, depending on the duration of exposure time. A longer period of exposure to nicotine produces a longer-lasting facilitation. In mice treated with nicotine for 7 d, the facilitation remains intact 24 h and 72 h after cessation of nicotine, but it completely disappears 8 d after nicotine was stopped. This longlasting facilitation of LTP induced by nicotine is consistent with previous findings in the hippocampal neurons, which show that the enhancement of NMDA current induced by chronic nicotine exposure (10 d i.p. administration) lasts for ∼8 d (Yamazaki et al. 2006b ). In contrast, we find that a short exposure to nicotine (24 h) induces a short-lasting facilitation of synaptic plasticity that completely disappears 24 h after cessation to nicotine. This exposure duration effect on LTP that is induced by nicotine in the amygdala is similar to the synaptic facilitation induced by 5-HT in the connection between sensory and motor neurons of Aplysia, in which a single, short exposure to 5-HT induces shortlasting facilitation (STF) and repeated exposures to 5-HT produces an enduring form of synaptic facilitation (LTF) (Hawkins et al. 2006 ).
Materials and Methods
Male C57BL6/J mice (6-to 12-wk-old) (Jackson Laboratories, Bar Harbor, Maine) were used for all experiments. Mice were kept in clear plastic cages (29.2 ‫ן‬ 19 ‫ן‬ 12.7 cm, N10 cage, Ancare) in groups of five with ad libitum food (Prolab IsoPro RMH3000, PMI Nutrition International) and water (autoclaved tap water). Mice were kept at a 12-h day/night cycle.
Mice were quickly decapitated, the whole brain was placed in ice-cold ACSF (artificial cerebrospinal fluid), and a block of tissue containing the amygdala was removed. Coronal sections (400 µM) were cut and transferred to an interface chamber (Fine Science Tools). Slices were submerged and constantly perfused with ACSF at a rate of 2 mL/min and bubbled with 95% O 2 and 5% CO 2 . The composition of ACSF was as follows (in mM): 124 NaCl, 1.2 MgSO 4 , 4 KCl, 1.0 NaH 2 PO 4 , 2 CaCL 2 , 26 NaHCO 3 , and 10 D-glucose. In some experiments, GABAergic antagonist PTX (50 µM) was present in the perfusion solution. The temperature of the slice was maintained at 27°C. Experiments were started 2-3 h after slices were dissected. Extracellular recordings were made using ACSF-filled glass electrodes (1-3 M). Stimuli were delivered at a rate of one per minute (0.017 Hz, 0.05-msec pulse duration) through concentric bipolar stainless steel electrodes (25-µM wire diameter, CBBRC75, FHC). To produce LTP in the cortical-LA synaptic pathway, the stimulating electrodes were placed in the external capsule (EC), which contained fibers from the auditory cortex to the LA (EC-LA). To produce LTP in the TH-LA pathway, the stimulating electrodes were placed in thalamic afferent fiber to the LA, which is located in the ventral part of the striatum just above the central nucleus of the amygdala (Huang and Kandel 2007) . To record from EC-LA and TH-LA pathways, recording electrodes were placed in the LA. To produce LTP in the LA-BL synaptic pathway, the stimulating electrodes were placed in the LA, and the recording electrodes were placed in the basolateral subdivision of amygdala. The stimulation intensity was adjusted to evoke the field potential that was ∼50%-60% of maximal amplitude. Baseline values were acquired over a period of 30 min before giving the LTP-inducing stimulation. In all synaptic pathways tested in this study, LTP was elicited by 3 ‫ן‬ 2 trains of 100-Hz tetanus (with 10-sec intertrain interval) 3 min apart. The pulse duration of stimulation during tetanus is 0.1 msec. Changes in synaptic strength were expressed relative to the normalized baseline (mean ‫ע‬ SEM). Statistical comparisons were performed using student's t-test. Nicotine hydrogen tartrate salt (Sigma) was dissolved in drinking water (2, 10, and 25 µg/mL) and administered continuously in the drinking water for 1 d or 7 d prior to the experiment day. For bath application, the following drugs were made in water and stored as concentrated stock solution and diluted 1000-fold when applied to the perfusion solution: D-APV (Sigma), mecamylamine hydrochloride (Sigma), D␤H (Sigma), and MLA (Tocris). 
